Poklepovic AS - Search Results

1

US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma.

Fischer RA, Ryan I, De La Torre K, Barnett C, Sehgal VS, Levy JB, Luke JJ, Poklepovic AS, Hurlbert MS. Fischer RA, et al. Among authors: poklepovic as. Crit Rev Oncol Hematol. 2024 Apr;196:104289. doi: 10.1016/j.critrevonc.2024.104289. Epub 2024 Feb 8. Crit Rev Oncol Hematol. 2024. PMID: 38341119 Free article. Review.

2

A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer.

Kim RD, Sanoff HK, Poklepovic AS, Soares H, Kim J, Lyu J, Liu Y, Nixon AB, Kim DW. Kim RD, et al. Among authors: poklepovic as. Cancer. 2020 Aug 1;126(15):3464-3470. doi: 10.1002/cncr.32964. Epub 2020 May 26. Cancer. 2020. PMID: 32453456 Free PMC article. Clinical Trial.

3

Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.

Booth L, Cruickshanks N, Tavallai S, Roberts JL, Peery M, Poklepovic A, Dent P. Booth L, et al. Cancer Biol Ther. 2014;15(12):1646-57. doi: 10.4161/15384047.2014.967992. Cancer Biol Ther. 2014. PMID: 25482938 Free PMC article.

4

Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.

Booth L, Roberts JL, Cruickshanks N, Grant S, Poklepovic A, Dent P. Booth L, et al. Mol Cancer Ther. 2014 Oct;13(10):2384-98. doi: 10.1158/1535-7163.MCT-14-0172. Epub 2014 Aug 7. Mol Cancer Ther. 2014. PMID: 25103559 Free PMC article.

5

Phase 2 Study of Sorafenib, Valproic Acid, and Sildenafil in the Treatment of Recurrent High-Grade Glioma.

Poklepovic AS, Shah P, Tombes MB, Shrader E, Bandyopadhyay D, Deng X, Roberts CH, Ryan AA, Hudson D, Sankala H, Kmieciak M, Dent P, Malkin MG. Poklepovic AS, et al. medRxiv [Preprint]. 2024 Apr 24:2024.04.23.24304634. doi: 10.1101/2024.04.23.24304634. medRxiv. 2024. PMID: 38712133 Free PMC article. Preprint.

6

Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43.

Dent P, Booth L, Roberts JL, Poklepovic A, Cridebring D, Reiman EM. Dent P, et al. Aging (Albany NY). 2021 Jul 12;13(13):17097-17117. doi: 10.18632/aging.203297. Epub 2021 Jul 12. Aging (Albany NY). 2021. PMID: 34252884 Free PMC article.

7

Phase I Cancer Trials and Palliative Care: Antagonism, Irrelevance, or Synergy?

Cassel JB, Del Fabbro E, Arkenau T, Higginson IJ, Hurst S, Jansen LA, Poklepovic A, Rid A, Rodón J, Strasser F, Miller FG. Cassel JB, et al. J Pain Symptom Manage. 2016 Sep;52(3):437-45. doi: 10.1016/j.jpainsymman.2016.02.014. Epub 2016 May 24. J Pain Symptom Manage. 2016. PMID: 27233136 Free article.

8

Approaches to High-Risk Resected Stage II and III Melanoma.

Yushak M, Mehnert J, Luke J, Poklepovic A. Yushak M, et al. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e207-e211. doi: 10.1200/EDBK_239283. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099653 Free article. Review.

9

BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.

Labadie BW, Liu P, Bao R, Crist M, Fernandes R, Ferreira L, Graupner S, Poklepovic AS, Duran I, Maleki Vareki S, Balar AV, Luke JJ. Labadie BW, et al. Among authors: poklepovic as. J Transl Med. 2019 Nov 25;17(1):386. doi: 10.1186/s12967-019-02144-7. J Transl Med. 2019. PMID: 31767020 Free PMC article.

10

Considering adjuvant therapy for stage II melanoma.

Poklepovic AS, Luke JJ. Poklepovic AS, et al. Cancer. 2020 Mar 15;126(6):1166-1174. doi: 10.1002/cncr.32585. Epub 2019 Dec 23. Cancer. 2020. PMID: 31869447 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page